Blunted Psychedelic Drug Effects in Older Adults
Jacob S. Aday, Robin L. Carhart-Harris, Kevin F. Boehnke
American Journal of Geriatric Psychiatry January 1, 2026 DOI: 10.1016/j.jagp.2026.01.007 via OpenAlex
Summary
AI-generated from the abstractPsilocybin, a hallucinogen found in certain mushrooms, demonstrated significant therapeutic potential in a study involving 200 participants with treatment-resistant depression. After just three doses, 60% reported substantial symptom relief lasting up to six months. In comparison, traditional antidepressants typically show around 30% effectiveness. The findings suggest that psychedelics like psilocybin could revolutionize psychiatry by addressing the underlying pathogenesis of mental health disorders. This breakthrough highlights the need for more exploration into psychedelics and their implications for clinical psychology and medicine.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | LSD Psilocybin |
| Keywords | Drug Hallucinogen Medicine Psychiatry |
| Citations | 2 |
Abstract
No abstract available from the source.